What does the new personalized cancer medicine approved in England mean for patients?
Today, a new personalized cancer treatment was approved for NHS use in England. But this was no ordinary drug approval. Larotrectinib (Vitrakvi) is a highly innovative new treatment that, unlike most cancer drugs, is designed to target specific changes in cancer cells’ DNA rather than where the cancer is growing in the body. This means patients with various types of […]
Continue reading »